(Q46123887)

English

More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus

scientific article published on 16 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/24028669

0 references

More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/24028669

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

W Polonsky

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

L Traylor

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

W Wei

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

R Shi

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

A Vlajnic

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

A Nicolucci

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

16 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/24028669

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

255-261

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24028669%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Overcoming patient barriers to initiating insulin therapy in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Primary care physician beliefs about insulin initiation in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Well-being and symptoms in relation to insulin therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Effects of insulin initiation on patient-reported outcomes in patients with type 2 diabetes: results from the durable trial.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: results from the A1chieve observational study.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) evaluated in insulin glargine trials shows greater responsiveness to improvements than the original DTSQ.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT (Implementing New Strategies

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Glargine versus NPH insulin: efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes--the glargine and aspart study (GLASS) a randomised cross-over study.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of Type 2 diabetes: The Canadian INSIGHT Study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective Diabetes Study Group

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12214

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46123887&oldid=2093823371"